Sponsor:
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
Code:
NCT04945460
Conditions
Hypertension, Pulmonary
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Sotatercept 0.3 mg/kg
Placebo
Sotatercept 0.3 mg/kg escalating to 0.7 mg/kg
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations